Literature DB >> 3313941

Evaluation of quantitative liver function tests in liver donors.

M Burdelski1, M Oellerich, P Lamesch, E Raude, B Ringe, P Neuhaus, S Bortfeld, C Kämmerling, H Raith, M Scheruhn.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3313941

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  8 in total

Review 1.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

Review 2.  The promise of organ and tissue preservation to transform medicine.

Authors:  Sebastian Giwa; Jedediah K Lewis; Luis Alvarez; Robert Langer; Alvin E Roth; George M Church; James F Markmann; David H Sachs; Anil Chandraker; Jason A Wertheim; Martine Rothblatt; Edward S Boyden; Elling Eidbo; W P Andrew Lee; Bohdan Pomahac; Gerald Brandacher; David M Weinstock; Gloria Elliott; David Nelson; Jason P Acker; Korkut Uygun; Boris Schmalz; Brad P Weegman; Alessandro Tocchio; Greg M Fahy; Kenneth B Storey; Boris Rubinsky; John Bischof; Janet A W Elliott; Teresa K Woodruff; G John Morris; Utkan Demirci; Kelvin G M Brockbank; Erik J Woods; Robert N Ben; John G Baust; Dayong Gao; Barry Fuller; Yoed Rabin; David C Kravitz; Michael J Taylor; Mehmet Toner
Journal:  Nat Biotechnol       Date:  2017-06-07       Impact factor: 54.908

3.  Lidocaine and monoethylglycinexylidide serum determinations to analyze liver function of cirrhotic patients after oral administration.

Authors:  A E Muñoz; C Miguez; M Rubio; M Bartellini; D Levi; A Podestá; V Niselman; R Terg
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

4.  Progressive liver functional impairment is associated with an increase in AST/ALT ratio.

Authors:  E Giannini; F Botta; A Fasoli; P Ceppa; D Risso; P B Lantieri; G Celle; R Testa
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

5.  Pharmacokinetics of lidocaine and its major metabolite- monoethylglycinexylidide (MEGX) in rabbits with experimental common bile duct obstruction.

Authors:  J Wójcicki; T Sulikowski; M Wójcicki; M Droździk; B Gawrońska-Szklarz; B Barcew-Wiszniewska; J Skowron; L Rózewicka; U Gołdyn
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Apr-Jun       Impact factor: 2.441

6.  Pre- and post-transplant assessment of liver function in paediatric liver transplantation.

Authors:  M Burdelski; M Oellerich; J Düwel; H Raith; M Scheruhn; B Ringe; B Rodeck; A Latta; R Pichlmayr; J Brodehl
Journal:  Eur J Pediatr       Date:  1992       Impact factor: 3.183

7.  Effect of lidocaine on in vivo hepatic function.

Authors:  B Mets; R Hickman; U Neveling; M Emms; D O Chalton
Journal:  Dig Dis Sci       Date:  1993-12       Impact factor: 3.199

8.  Consequences of cold-ischemia time on primary nonfunction and patient and graft survival in liver transplantation: a meta-analysis.

Authors:  James E Stahl; Jennifer E Kreke; Fawaz Ali Abdul Malek; Andrew J Schaefer; Joseph Vacanti
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.